Jessica Tuan, MD, MS

Dr. Tuan's underlying interests in Infectious Diseases focus on HIV/AIDS and global health. She completed her Biomedical Engineering undergraduate degree at Johns Hopkins University and Biomedical Engineering Master's Degree at Yale University. She graduated from Chicago Medical School. She completed Internal Medicine residency at University of Connecticut School of Medicine and Infectious Diseases fellowship at Yale School of Medicine.

She is an ABIM Board-certified Instructor of Medicine in Infectious Diseases at Yale School of Medicine. She is a Principal Investigator for the following Yale School of Medicine research studies: 1) Qualitative Assessment of SARS-CoV-2 Immunogenicity after COVID-19 vaccination in People Living with HIV, 2) Real-World Utilization of Sotrovimab for COVID-19, 3) Evaluating Pitavastatin to Reduce Risk of Cardiovascular Disease in HIV-Infected Adults (REPRIEVE) (NIH/ACTG-funded clinical trial), 4) Pfizer mRNA Influenza vaccine clinical trial.

She is a Sub-Investigator for the Yale Pfizer/BioNTech (adult, pediatric, booster) & Sanofi COVID-19 vaccine clinical trials. She is a Sub-Investigator for Yale School of Medicine HIV clinical trials: 1) Evaluating the Safety and Efficacy of Bictegravir/Lenacapavir Versus Stable Baseline Regimen in Virologically Suppressed People With HIV-1 on Stable Complex Treatment Regimens, 2) Evaluating Efficacy, Safety, Tolerability of Switching to Long-acting Cabotegravir + Rilpivirine every 2 months (from BIC/FTC/TAF) in Adults with HIV-1. Her other research study is Assessing Attitudes & Readiness for HIV PrEP among Adolescents & Young Women in Liberia.

She was awarded the Yale Institute for Global Health Leadership in Global Health Fellowship as a World Bank COVID-19 Vaccine & Primary Health Care Fellow. She was a Yale Johnson & Johnson Global Health Scholar in KwaZulu-Natal, South Africa (2022), Kigali, Rwanda (2019) and Butare, Rwanda (2017). She is a violinist in the Yale Medical Symphony Orchestra.